DALU, DAVIDE
DALU, DAVIDE
Dipartimento di Scienze Biomediche e Cliniche
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients
2024 D. Dalu, M. Tarkowski, L. Ruggieri, M.S. Cona, A. Gabrieli, D. De Francesco, C. Fasola, S. Ferrario, A. Gambaro, E. Masedu, G. Parma, E. Rulli, C. De Stradis, D. Mavilio, F. Calcaterra, F. Manoni, A. Riva, N. La Verde
Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology
2023 A.G. Leone, R. Miceli, D. Trapani, M. Massagrande, F. Morano, S. Marsoni, N. La Verde, R. Berardi, R. Casolino, M. Lambertini, D. Dalu, M. Di Maio, G.D. Beretta, F. Perrone, S. Cinieri, F. Pietrantonio
Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients
2021 S. Demurtas, N. La Verde, S. Rota, G. Casazza, C. Montrasio, S. Cheli, M.S. Cona, D. Dalu, C. Fasola, S. Ferrario, V. Filipazzi, A. Gambaro, N. Tosca, E. Clementi
ABCB1 c.3435C > T polymorphism is associated with platinum toxicity: a preliminary study
2019 B. De Troia, D. Dalu, V. Filipazzi, L. Isabella, N. Tosca, S. Ferrario, A.R. Gambaro, L. Somma, C. Fasola, S. Cheli, E. Clementi, D. De Francesco, F.S. Falvella, M.T. Cattaneo
A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project
2016 N. La Verde, F. Corsi, A. Moretti, B. Peissel, D. Dalu, S. Girelli, C. Fasola, A. Gambaro, G. Roversi, J. Azzollini, P. Radice, V. Pensotti, G. Farina, S. Manoukian